- Politics
- Diversity, equity and inclusion
- Financial Decision Making
- Telehealth
- Patient Experience
- Leadership
- Point of Care Tools
- Product Solutions
- Management
- Technology
- Healthcare Transformation
- Data + Technology
- Safer Hospitals
- Business
- Providers in Practice
- Mergers and Acquisitions
- AI & Data Analytics
- Cybersecurity
- Interoperability & EHRs
- Medical Devices
- Pop Health Tech
- Precision Medicine
- Virtual Care
- Health equity
WELL Health Acquires Nerd EMR and Butterfly for $2.55M
WELL hopes the acquisition will leverage emerging technologies to materially augment the patient journey.
This photo has been resized. Courtesy of well.company.
WELL Health Technologies has acquired two private companies, NerdEMR (electronic medical record) Services and Butterfly Medical Limited, to further its goal of consolidating and modernizing clinical and digital assets within the primary healthcare sector.
NerdEMR, who, according to the company, is British Columbia’s largest open source clinical application resource (OSCAR) EMR service provider, delivers software as a service to approximately 220 medical clinics. Its system supports approximately 2,000 registered practitioners, 1,700 staff and 4.85 million registered patients.
>> READ: Global Hospital EMR Systems Market: Key Growth Drivers
NerdEMR’s founders and team, led by Mike Thompson and Pat Morphy, joined WELL’s technology division.
“We share a vision of improving medical practice efficiency and patient outcomes, while leveraging emerging technologies and tools to empower our patients and streamline clinical workflows for our caregivers,” said Thompson, co-founder and CEO of NerdEMR.
Butterfly is a medical device startup that aims to improve the standard of care for men suffering from Benign Prostate Hyperplasia. They own certain intellectual property relating to the growth and consolidation of EMR companies related to the OSCAR platform.
“…We believe that close collaboration between our clinical and digital business units will allow us to materially augment the patient journey and support our physician partners to drive better outcomes,” said Hamed Shahbazi, founder and CEO of WELL.
WELL paid a total of $2.55 million for the acquisitions.
Get the best insights in healthcare analytics directly to your inbox.
Related
Mission Bio Raises $30M for Cancer-Focused Precision Medicine Tech
Hospitals continue to struggle with IV fluid shortage, with some still delaying surgeries
November 25th 2024Some health systems have developed conservation strategies, and Baxter International has resumed production at its North Carolina plant. But some facilities are still facing serious challenges.
